Healthcare Heavy IPO Week Heading into Holiday

A total of 12 IPOs could potentially debut this week which includes one holdover from last week, LoanDepot Inc (LDI).

Looking for color, commentary and ratings on which IPOs are generating the most demand. Place IPO Boutique on your team.

https://www.ipoboutique.com/blog/register/

Debuting Tuesday (2/9)

Adagene Inc. (ADAG) — They are a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies.

Cloopen Group Holding Limited (RAAS) — They are the largest multi-capability cloud-based communications solution provider in China, as measured by revenues in 2019, according to the CIC report.

Debuting Wednesday (2/10)

Viant Technology Inc (DSP) —  They are an advertising software company. Their software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process.

Debuting Thursday (2/11)

Apria Inc. (APR) —  They are a leading provider of integrated home healthcare equipment and related services in the United States.

AFC Gamma Inc (AFCG) —  AFC Gamma, Inc. is a commercial real estate finance company founded in July 2020 by a veteran team of investment professionals.

Bioventus Inc (BVS) —  They are a global medical device company focused on developing and commercializing clinically differentiated, cost efficient and minimally invasive treatments that engage and enhance the body’s natural healing process.

Bumble Inc (BMBL) — The Bumble brand was built with women at the center—where women make the first move.

Signify Health Inc (SGFY) —     Signify Health is a leading healthcare platform that leverages advanced analytics, technology, and nationwide healthcare provider networks to create and power value-based payment programs.

Debuting Friday (2/12)

Decibel Therapeutics, Inc. (DBTX) – They are a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for hearing and balance disorders, one of the largest areas of unmet need in medicine. 

NexImmune, Inc. (NEXI) – They are a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body’s own T cells to generate a specific, potent and durable immune response that mimics natural biology.

Talis Biomedical Corporation (TLIS) – Talis aims to transform diagnostic testing by developing and commercializing innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases and other conditions at the point-of-care.